Cart
sales@molnova.com
SB-277011
CAS No. 215803-78-4
SB-277011( SB-277011-A | SB-277011A | SB277011 | SB 277011 )
Catalog No. M13441 CAS No. 215803-78-4
A potent and selective dopamine D3 receptor antagonist with pKi of 8.0.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 80 | Get Quote |
|
| 10MG | 128 | Get Quote |
|
| 25MG | 240 | Get Quote |
|
| 50MG | 401 | Get Quote |
|
| 100MG | 590 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSB-277011
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and selective dopamine D3 receptor antagonist with pKi of 8.0.
-
DescriptionA potent and selective dopamine D3 receptor antagonist with pKi of 8.0; displays >100-fold selectivity against the D2, 5-HT1B, and 5-HT1D receptors; exhibits high oral bioavailability and brain penetration in rats.Schizophrenia Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsSB-277011-A | SB-277011A | SB277011 | SB 277011
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine Receptor
-
Research AreaNeurological Disease
-
IndicationSchizophrenia
Chemical Information
-
CAS Number215803-78-4
-
Formula Weight438.564
-
Molecular FormulaC28H30N4O
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC1CC(CCC1CCN2CCC3=C(C2)C=CC(=C3)C#N)NC(=O)C4=CC=NC5=CC=CC=C45
-
Chemical Name4-Quinolinecarboxamide, N-[trans-4-[2-(6-cyano-3,4-dihydro-2(1H)-isoquinolinyl)ethyl]cyclohexyl]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Stemp G, et al. J Med Chem. 2000 May 4;43(9):1878-85.
2. Reavill C, et al. J Pharmacol Exp Ther. 2000 Sep;294(3):1154-65.
3. Ashby CR Jr, et al. J Pharmacol Exp Ther. 2000 Sep;294(3):1166-74.
molnova catalog
related products
-
3-CPMT
3-CPMT is a dopamine uptake inhibitor and a potent long-acting antihistaminic agent.
-
SKF-83566
SKF-83566 is a blood-brain permeable and orally active antagonist of D1-like dopamine receptor and a weaker competitive 5-HT2 receptor antagonist with Ki of 11 nMSKF-83566 caused a concentration-dependent increase in peak single-pulse evoked extracellular DA concentration, with a maximum increase of 65% in 5 μM SKF-83566.?
-
Seridopidine
Seridopidine (ACR343) is a modulator of dopaminergic activity that is used as an oral therapy for schizophrenia, Parkinson's disease, and Tourette's syndrome.
